Loading...
Bruker Corporation
BRKR•NASDAQ
Healthcare
Medical - Devices
$41.94
$1.49(3.68%)
Bruker Corporation (BRKR) Financial Performance & Income Statement Overview
Review Bruker Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.56%
↑ 13.56%
Operating Income Growth
-42.07%
↓ 42.07%
Net Income Growth
-73.53%
↓ 73.53%
Operating Cash Flow Growth
-28.22%
↓ 28.22%
Operating Margin
7.14%
↑ 7.14%
Gross Margin
48.87%
↑ 48.87%
Net Profit Margin
2.31%
↑ 2.31%
ROE
4.41%
↑ 4.41%
ROIC
5.36%
↑ 5.36%
Bruker Corporation (BRKR) Income Statement & Financial Overview
Review Bruker Corporation's (BRKR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $979.60M | $864.40M | $800.70M | $721.70M |
| Cost of Revenue | $486.30M | $454.20M | $411.20M | $365.20M |
| Gross Profit | $493.30M | $410.20M | $389.50M | $356.50M |
| Gross Profit Ratio | $0.50 | $0.47 | $0.49 | $0.49 |
| R&D Expenses | $104.40M | $98.10M | $92.20M | $81.80M |
| SG&A Expenses | $247.30M | $229.90M | $221.30M | $195.30M |
| Operating Expenses | $421.20M | $350.70M | $315.40M | $277.90M |
| Total Costs & Expenses | $907.50M | $796.30M | $726.60M | $650.20M |
| Interest Income | $0.00 | $1.90M | $2.40M | $2.60M |
| Interest Expense | -$8.00M | $11.60M | $15.70M | $6.80M |
| Depreciation & Amortization | $0.00 | $51.00M | $45.20M | $34.70M |
| EBITDA | $72.10M | $119.10M | $125.90M | $114.10M |
| EBITDA Ratio | $0.07 | $0.14 | $0.15 | $0.16 |
| Operating Income | $72.10M | $68.10M | $74.10M | $78.60M |
| Operating Income Ratio | $0.07 | $0.08 | $0.09 | $0.11 |
| Other Income/Expenses (Net) | -$17.70M | -$12.80M | -$24.20M | $6.80M |
| Income Before Tax | $54.40M | $55.30M | $23.90M | $71.60M |
| Income Before Tax Ratio | $0.06 | $0.06 | $0.03 | $0.10 |
| Income Tax Expense | $40.70M | $14.80M | $16.10M | $19.80M |
| Net Income | $13.70M | $40.90M | $7.60M | $50.90M |
| Net Income Ratio | $0.01 | $0.05 | $0.009 | $0.07 |
| EPS | $0.09 | $0.28 | $0.05 | $0.35 |
| Diluted EPS | $0.09 | $0.28 | $0.05 | $0.35 |
| Weighted Avg Shares Outstanding | $151.60M | $148.10M | $147.40M | $145.20M |
| Weighted Avg Shares Outstanding (Diluted) | $152.00M | $148.70M | $148.00M | $145.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan